Gangling Chen

Dr. Gangling Chen


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
GCGangling Chen
Gangling Chen
YXYe Xinyi
Ye Xinyi
JZJiangwei Zhang
Jiangwei Zhang
TTTingli Tang
Tingli Tang
LLLin Li
Lin Li
JKJunping Kou
Junping Kou
Limb remote ischemic postconditioning (LRIP) has been confirmed to reduce the ischemia-reperfusion injury but its mechanisms are still not clear. This study clarified the mechanism of LRIP based on the nicotinamide-adenine dinucleotide phosphate (NADPH) oxidase and Myeloid differentiation factor 88 (MyD88)-Tumor necrosis factor (TNF) receptor-associated factor 6 (TRAF6)-P38 pathway of neutrophils. Rat middle cerebral artery occlusion (MCAO) model was used in this study. Ischemia-reperfusion injury was carried out by MCAO 1.5 h followed by 24 h reperfusion. LRIP operation was performed to the left femoral artery at 0, 1 or 3 h after reperfusion. Behavioral testing, including postural reflex test, vibrissae-elicited forelimb placing test and tail hang test, showed that LRIP operated at 0 h of reperfusion could significantly ameliorate these behavioral scores. Pathological examinations, infarct size, Myeloperoxidase (MPO) activity showed that LRIP operated at 0 h of reperfusion could significantly ameliorate the pathological scores, reduce the infarct size and MPO activity in the brain and increase the MPO activity in the left leg. By using Neutrophil counting, immunofluorescence and real-time PCR techniques, we found that LRIP operated at 0 h of reperfusion could reduce neutrophil counts in the peripheral blood and downregulate the activation of neutrophil in the peripheral blood and rat brain. Western blots revealed that MyD88, TRAF6, p38 mitogen-activated protein kinase (p38-MAPK) in neutrophils and the phosphorylation of p47phox (Ser 304 and Ser 345) in neutrophil could be downregulated by LRIP. Our study suggests that LRIP inhibits the number and activation of neutrophils in the rat brain and peripheral blood linked to down-regulating the activation of NADPH oxidase in neutrophils by MyD88/TRAF6/p38-MAPK pathway.

1 May 2019 in Journal of Pharmacy and Pharmacology
Verified
Journal Article
Closed access
GCGangling Chen
Gangling Chen
CLCaihong Liu
Caihong Liu
GMGuoliang Meng
Guoliang Meng
CZChunteng Zhang
Chunteng Zhang
FCFang Chen
Fang Chen
CZChaofeng Zhang
Chaofeng Zhang

1 December 2015 in Chinese Journal of Natural Medicines
Verified
Journal Article
Closed access
QWQi Wu
Qi Wu
GCGangling Chen
Gangling Chen
YLYa-Juan Li
Ya-Juan Li
YCYang Chen
Yang Chen
FLFang-Zhen Lin
Fang-Zhen Lin

2 June 2020 in Korean Journal of Chemical Engineering
Verified
Journal Article
Closed access
PDF file
TMTian-Lin Ma
Tian-Lin Ma
JDJianfei Ding
Jianfei Ding
XLXueli Liu
Xueli Liu
GCGangling Chen
Gangling Chen
JZJiandong Zheng
Jiandong Zheng

20 August 2023 in Phytomedicine
Verified
Journal Article
Closed access
SZSanli Zhang
Sanli Zhang
YYYan Yu
Yan Yu
MSMingyue Sheng
Mingyue Sheng
XCXun Chen
Xun Chen
QWQi Wu
Qi Wu
GCGangling Chen
Gangling Chen

31 March 2023 in Frontiers in Pharmacology
Verified
Journal Article
Open access
MSMingyue Sheng
Mingyue Sheng
XCXun Chen
Xun Chen
YYYan Yu
Yan Yu
QWQi Wu
Qi Wu
JKJunping Kou
Junping Kou
GCGangling Chen
Gangling Chen
Backgrounds: The circadian clock protein Rev-erbα is a crucial regulator of circadian rhythms that affects multiple molecular, cellular, and physiology pathways that control susceptibility, injury, and recovery in the neurological disorders. Emerging evidence suggest that Rev-erbα plays a key role in the inflammation and oxidative stress, two pivotal mechanisms in the pathogenesis, progression, and recovery process of ischemic stroke. However, it remains inconclusive whether Rev-erbα activation is protective against ischemic brain damage. Nuclear factor erythroid 2-related factor 2 (Nrf2) pathway, a master regulator of inflammatory and oxidative responses. Our study aimed to determine whether pharmacological activation of Rev-erbα by SR9009 protects against acute ischemic brain damage partly via Nrf2 pathway.Methods: Adult mice were pretreated with SR9009 or Nrf2 inhibitor all-trans-retinoic acid (ATRA) for 3 days prior to Sham or middle cerebral artery occlusion (MCAO) operation. After ischemia for 1 h and reperfusion for 24 h, the neurological function and cerebral infarction volume were determined, superoxide dismutase (SOD) activity, malondialdehyde (MDA) content and glutathione peroxidase (GSH-PX) activity in serum were detected by kit. The mRNA and/or protein level of tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), inducible nitric oxide synthase (iNOS), Period (Per)1, Brain and muscle arnt-like1 (Bmal1), Circadian locomotor output cycles kaput (Clock), Rev-erbα, Nrf2, heme oxygenase-1 (HO-1) and quinone oxidoreductase 1 (NQO1) in cerebral cortex were detected by q-PCR and Western blot.Results: We confirmed that SR9009 activated Rev-erbα gene in the cerebral cortex under basal condition. At 24 h after reperfusion, SR9009 ameliorated acute neurological deficits, reduced infarct volume. Meanwhile, the inflammatory TNF-α, IL-1β, iNOS and MDA content levels were significant decreased, SOD and GSH-PX activity were obviously increased, which were markedly blunted (or abolished) by ATRA. SR9009 enhanced the induction of Nrf2 and its downstream target genes HO-1 and NQO1 after ischemic insult. In addition, we found that SR9009 restored Rev-erbα, Bmal1, Clock, Per1 genes expression in the cerebral cortex under ischemic condition.Conclusion: Taken together, Rev-erbα activation by SR9009 protects against ischemic stroke damage, at least, partly through Nrf2 pathway.